EXAMS · SÃO PAULO
Tumor markers (CA 19-9, CA 125, CA 15-3, CA 72-4): cost and procedure
Understand the role of each marker measured in the blood and how the blood draw supports medical monitoring.

Understand the exam
Tumor markers are substances produced by cancer cells or other body cells in response to cancer or certain benign (noncancerous) conditions. Measured periodically after treatment, they may help the doctor check whether the disease has returned.
Each abbreviation is associated with certain cancers: CA 19-9 with pancreatic, gallbladder, bile duct and stomach cancers; CA 125 with ovarian cancer; and CA 15-3 with breast cancer.
To diagnose cancer, results from these tests are usually combined with other tests, such as biopsies or imaging. Repeated measurements during treatment may indicate whether the tumor is responding.
How it is done
Blood is drawn from a vein in the arm using a small needle and collected in a tube. Laboratories use different methods to measure CA 19-9; people repeating the test to monitor treatment usually use the same method and laboratory so results can be compared.
The clinic's records list the item as Blood tumor markers (CA 19.9, CA 125, CA 72-4, CA 15-3, etc, with no duration in minutes or preparation specified. When scheduling, show your order so the team can identify which markers will be measured.
When it is recommended
- Monitoring how well treatment is working
- Periodic follow-up after treatment to watch for possible recurrence
- Supporting ovarian cancer diagnosis along with other tests (CA 125)
- Monitoring some digestive system cancers, such as pancreatic, bile duct and stomach cancers (CA 19-9)
- In breast cancer, checking whether treatment is working or the disease has returned (CA 15-3)
Does the exam hurt?
During the blood draw, you may feel a small prick as the needle goes in or out. There may be mild pain or bruising at the site, which usually goes away quickly.
After the exam
Cost and health plans
| Exam | Self-pay | Duration | Health plans |
|---|---|---|---|
| CA 72-4 | From R$ 48.42 (≈ US$ 9, estimated) | Confirm with the team | Ask the team about coverage |
| CA19/9 | From R$ 86.40 (≈ US$ 16, estimated) | Confirm with the team | Ask the team about coverage |
| CA15-3 | From R$ 86.40 (≈ US$ 16, estimated) | Confirm with the team | Ask the team about coverage |
| CA 15 - 3 | From R$ 86.40 (≈ US$ 16, estimated) | Confirm with the team | Ask the team about coverage |
| CA 125 II | From R$ 93.60 (≈ US$ 17, estimated) | Confirm with the team | Ask the team about coverage |
| Blood tumor markers (CA 19.9, CA 125, CA 72-4, CA 15-3, etc | From R$ 173.00 (≈ US$ 31, estimated) | Confirm with the team | Ask the team about coverage |
The team confirms the requested option, coverage, and conditions before booking.
Book an examFrequently asked questions
What is the difference between CA 19-9, CA 125, CA 15-3 and CA 72-4?
In the clinic's records, they are grouped under Blood tumor markers (CA 19.9, CA 125, CA 72-4, CA 15-3, etc. CA 19-9 is associated with pancreatic, gallbladder, bile duct and stomach cancers; CA 125 with ovarian cancer; and CA 15-3 with breast cancer.
Do I need to fast for tumor marker testing?
The records list no fixed preparation for this variant. The team provides instructions when you schedule.
Does a high tumor marker mean cancer?
Not necessarily. Noncancerous conditions, such as endometriosis, uterine fibroids and liver disease, can also raise CA 125. Also, not everyone with cancer has elevated markers, so the result is usually combined with other tests, such as a biopsy or imaging.
How long does the HIV blood draw take at the laboratory?
The records do not list a duration in minutes for this test. The team provides instructions when you schedule.
How much does the test cost, and how can I confirm health plan coverage?
The self-pay price is in the pricing table on this page, with the date the records were accessed. For health plans, check the plans listed on the page and send your order to the service team: they confirm coverage for each marker.
How are test results used?
The doctor compares results from repeated blood draws, which may indicate during treatment whether the tumor is responding. The records do not list a report turnaround time, and this page does not promise one; the team tells you when you will receive the results.
Where we see patients
References
- National Cancer Institute (NCI). Tumor Markers. NCI/NIH. 2023.
- National Cancer Institute (NCI). Tumor Marker Tests in Common Use. NCI/NIH. 2023.
- MedlinePlus (U.S. National Library of Medicine). Tumor Marker Tests. NLM/NIH. 2024.
- MedlinePlus (U.S. National Library of Medicine). CA 19-9 Blood Test (Pancreatic Cancer). NLM/NIH. 2024.
- MedlinePlus (U.S. National Library of Medicine). CA-125 Blood Test (Ovarian Cancer). NLM/NIH. 2024.
This content is informational and does not replace a consultation.
Updated on